Read the Registration Document - Guerbet

More documents

Recommendations

Info

Debt waiver agreements granted to affiliated undertakings and implemented in 2012:A debt waiver was granted to Medex for €4,553,000 with a financial recovery clause.Note 23 – Stock options and stock purchase optionsGrant datePlan of26/07/2005Plan of26/03/2009Plan of17/10/2011Plan of23/11/2011Plan of20/02/2012Tax availability date 26/07/2007 26/03/2011 17/10/2015 23/11/2015 20/02/2016Number of options granted: 106,950 6,000 132,710 12,000 1,700o.w. Yves L’Epine---12,000-o.w. Bruno Bonnemain2,000-4,000--Subscription or purchase price € 82.91 € 112.26 € 61.60 € 64.30 € 61.50Plan expiration date 25/07/2012 25/03/2019 16/10/2021 22/11/2021 20/02/2022Number of options exercised 16,023 - - - -Number of options cancelled 90,927 4,000 13,110 - -Number of options outstanding - 2,000 119,600 12,000 1,700Note 24 – Financial instruments subject to potential market risksThe fair value of treasury instruments is -€2.24 million for interest rate hedges and -€0.018 million forforeign exchange hedges.At 31 December 2012 there were 11 interest rate hedges for €100.42 million. Total open positions arepresented below in detail:InceptiondateExpirationdateContracttypePositionGuerbetBenchmarkContractrateFair value(in €)Notional amount(in €)30/11/2006 04/12/2013 Swap Purchase 3 Month Euribor 3.7754% -48,667.25 2,142,857.1420/06/2008 20/06/2013 Swap Purchase 3 Month Euribor 5.1250% -12,510.66 500,000.0015/06/2009 15/06/2014 Swap Purchase 3 Month Euribor 2.4920% -91,541.38 4,500,000.0009/12/2009 12/12/2016 Cap Purchase 3 Month Euribor 2.5300% -81,488.78 5,714,285.7117/12/2009 17/12/2014 Cap Purchase 3 Month Euribor 2.3000% -24,165.17 4,000,000.0028/09/2010 28/09/2013 Swap Purchase 3 Month Euribor 1.2025% -13,032.51 2,500,000.0029/03/2011 31/03/2018 Swap Purchase 3 Month Euribor 2.7750% -1,044,418.86 16,125,000.0030/06/2011 04/07/2016 Swap Purchase 3 Month Euribor 2.2950% -153,145.80 3,750,000.0004/11/2011 08/11/2016 Swap Purchase 3 Month Euribor 1.4350% -194,166.78 8,000,000.0010/11/2011 14/11/2016 Swap Purchase 3 Month Euribor 1.4525% -196,817.69 8,000,000.0009/07/2012 30/06/2017 Swap Purchase 3 Month Euribor 0.7250% -380,042.75 45,187,500.00131
With respect to the management of foreign exchange risk, 74 forward exchange hedging contracts werenegotiated in 2012 including 3 still open at 31 December for €1.13 million. Total open positions arepresented below in detail:InceptiondateExpirationdateTypeSpot tradeHedgingrateAmount(in €)Amount(in currency)Fair value27/11/2012 09/01/201329/11/2012 09/01/201329/11/2012 05/02/2013USD SwappurchaseUSD SwappurchaseUSD Swappurchase1.2980 1.2985 159,934.54 207,675.00 -2,545.611.2975 1.2979 612,007.86 794,325.00 -10,019.371.2975 1.2983 354,829.39 460,675.00 -5,781.56Note 25 – Compensation to officers2012 2011Compensation granted to officers 651 560This refers to compensation paid to executives of the company in their capacity as officers and salariedemployees.Note 26 – Average number of personnel during the year2012 2011Office and plant workers 203 209Technicians, supervisors, sales representatives 432 418Management 253 246Total 888 873Note 27 – Off-balance sheet commitments2012 2011Guarantees and security and other commitments granted to third parties on behalf ofassociates 9,893 13,009Guarantees and security granted to third parties 3,384 3,141Receivables assigned within the framework of securitisation programmes 10,998 12,417Property and equipment capital lease commitments: 508 650- less than 1 year 130 141- between 1 and 5 years 379 509- greater than five years - -Guaranteed debt - -Total 24,783 29,217Capital lease payments in2012Capital lease payments in2011On property leases - -On equipment leases 141 -Total 141 -132
Page 3 and 4:
CONTENTSCHIEF EXECUTIVE OFFICERS’
Page 5 and 6:
CHIEF EXECUTIVE OFFICERS’ MESSAGE
Page 7 and 8:
THE GUERBET GROUP1) History of the
Page 9 and 10:
3) Business overview3.1 Guerbet is
Page 11 and 12:
3.4 The pathologiesIn Oncology, the
Page 13:
Guerbet's offering of products is c
Page 16 and 17:
c) Research & development• R&D ob
Page 18 and 19:
• A proactive partnering strategy
Page 20 and 21:
5) Group organisation at 31 Decembe
Page 22 and 23:
e) DistributionGuerbet distribute i
Page 24 and 25:
DirectorsOther offices and director
Page 26 and 27:
There exist no arrangements or unde
Page 28 and 29:
Summary of compensation for Marie-C
Page 30 and 31:
• Stock options granted to non-of
Page 32 and 33:
I - 1Organisation of the work of th
Page 34 and 35:
"Research and Innovation" Committee
Page 36 and 37:
II - Internal control and risk mana
Page 38 and 39:
4) Statutory Auditors’ report pre
Page 40 and 41:
SHAREHOLDER INFORMATION1) The Guerb
Page 42 and 43:
As at 31 December 2010SHARESVOTING
Page 44 and 45:
considered to have automatically re
Page 46 and 47:
10) Provisions of the Articles of A
Page 48 and 49:
c) Earnings highlightsIFRS(in thous
Page 50 and 51:
g) OutlookStrongly focused on the n
Page 52 and 53:
3) Risk factorsThe company conducte
Page 54 and 55:
• Sourcing risksGuerbet has an ex
Page 56 and 57:
• Information technology risksAn
Page 58 and 59:
• Five-year summary of consolidat
Page 60 and 61:
• Other information included in t
Page 62 and 63:
• Recruitment and dismissalsGuerb
Page 64 and 65:
and employee savings. The goal is s
Page 66 and 67:
• Measures adopted to promote emp
Page 68 and 69:
) Pollution and waste managementThe
Page 70 and 71:
3) Societal informationa) Territori
Page 72 and 73:
• Consolidated income statementIn
Page 74 and 75:
In thousands of euros• Statement
Page 76 and 77:
Changes in standards and interpreta
Page 78 and 79:
g) Research and development expendi
Page 80 and 81:
Held to maturity investmentsHeld-to
Page 82 and 83: creation are recorded under "Other
Page 84 and 85: III) Notes to the financial stateme
Page 86 and 87: Aged trial balance information for
Page 88 and 89: 2.2 - Borrowings by currencyCurrenc
Page 90 and 91: 3.3 - Analysis of the sensitivity o
Page 92 and 93: Revenue2012European companiesfor th
Page 94 and 95: In 2005, the Group acquired for ¥5
Page 96 and 97: 6.2 - Analysis of property, plant a
Page 98 and 99: The change in the net value of inve
Page 100 and 101: 12.2 - Accrued employee benefitsa)
Page 102 and 103: Change in net liabilities of the pe
Page 104 and 105: 14.4 - Personnel by region at year-
Page 106 and 107: Note 22 - Research and development
Page 108 and 109: Note 25 - Related parties25.1 - Rel
Page 110 and 111: Note 27 - Basic earnings per share
Page 112 and 113: 2) Auditors’ report on the consol
Page 114 and 115: 3) Parent company financial stateme
Page 116 and 117: • Income statementIn thousands of
Page 118 and 119: • Statement of cash flowsIn milli
Page 120 and 121: c) Property, plant and equipmentPro
Page 122 and 123: Note 1 - Intangible assets1 - 1 - C
Page 124 and 125: Note 6 - Receivables by maturityCos
Page 126 and 127: Note 9 - Regulated provisionsInvest
Page 128 and 129: Note 13 - Sales by region2012 2011F
Page 130 and 131: Tax income or expense recorded in t
Page 134 and 135: Capital lease commitments relative
Page 136 and 137: 4) Auditors' report on the separate
Page 138 and 139: 5) Auditors' special report on rela
Page 140 and 141: ORDINARY AND EXTRAORDINARY GENERAL
Page 142 and 143: RESOLUTION THREE (Special report of
Page 144 and 145: Extraordinary resolutionsRESOLUTION
Page 146 and 147: 3) Report of the Board of Directors
Page 148 and 149: Application of legal provisions gov
Page 150 and 151: • Tenth draft resolution: stock s
Page 152 and 153: 2) The Statutory Auditorsa) Statuto
Page 154 and 155: 6) Articles of association (selecte
Page 156 and 157: 7) 2013 shareholders calendarEventD
Page 158 and 159: ) Annual financial reportInformatio
show all

Read the Registration Document - Guerbet

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?